Topical tacrolimus shows promise against persistent subepithelial infiltrates

This case series assessed the efficacy and safety of topical tacrolimus for subepithelial infiltrates (SEIs) due to adenoviral keratoconjunctivitis (AKC) persisting at least 2 years after treatment.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553